BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37461351)

  • 41. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
    Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
    Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
    Li YJ; Dong M; Kong FM; Zhou JP
    Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
    Zhang L; Gong F; Zhang F; Ma J; Zhang P; Shen J
    Int J Nanomedicine; 2013; 8():1517-24. PubMed ID: 23620667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium.
    Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application.
    Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N
    Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A promising targeted gene delivery system: folate-modified dexamethasone-conjugated solid lipid nanoparticles.
    Wang W; Zhou F; Ge L; Liu X; Kong F
    Pharm Biol; 2014 Aug; 52(8):1039-44. PubMed ID: 24611745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactive Oxygen Species and Folate Receptor-Targeted Nanophotosensitizers Composed of Folic Acid-Conjugated and Poly(ethylene glycol)-Chlorin e6 Tetramer Having Diselenide Linkages for Targeted Photodynamic Treatment of Cancer Cells.
    Yang SW; Jeong YI; Kook MS; Kim BH
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
    Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
    Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
    Vangara KK; Liu JL; Palakurthi S
    Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual tumor-targeted poly(lactic-
    Chen J; Wu Q; Luo L; Wang Y; Zhong Y; Dai HB; Sun D; Luo ML; Wu W; Wang GX
    Int J Nanomedicine; 2017; 12():5745-5760. PubMed ID: 28848351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanism of carrier-mediated transport of folates in BeWo cells: the involvement of heme carrier protein 1 in placental folate transport.
    Yasuda S; Hasui S; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biosci Biotechnol Biochem; 2008 Feb; 72(2):329-34. PubMed ID: 18256483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast Tumor Targeting with PAMAM-PEG-5FU-
    Narmani A; Arani MAA; Mohammadnejad J; Vaziri AZ; Solymani S; Yavari K; Talebi F; Darzi SJ
    Biomed Microdevices; 2020 Apr; 22(2):31. PubMed ID: 32335724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J; Li S; Shen Q; He H; Zhang Y
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
    Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
    Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier.
    Correia Carreira S; Cartwright L; Mathiesen L; Knudsen LE; Saunders M
    Placenta; 2011 Mar; 32(3):283-91. PubMed ID: 21236486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
    Xin Y; Liu T; Yang C
    Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research on nanoparticles in human perfused placenta: State of the art and perspectives.
    Aengenheister L; Favaro RR; Morales-Prieto DM; Furer LA; Gruber M; Wadsack C; Markert UR; Buerki-Thurnherr T
    Placenta; 2021 Jan; 104():199-207. PubMed ID: 33418345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent.
    Ngernyuang N; Seubwai W; Daduang S; Boonsiri P; Limpaiboon T; Daduang J
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():411-415. PubMed ID: 26706547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.